Save on Sotatercept-Csrk with Coupons, Discounts & Savings Programs


Start Saving Today!
Lower the Cost of Your Sotatercept-Csrk Prescription
More great savings
View Related Brands
MEDICAL INFORMATION
Sotatercept-Csrk Key Facts
What dosages is Sotatercept-Csrk available in?
Sotatercept-Csrk is available as a 45 mg or 60 mg single-dose vial.
What is Sotatercept-Csrk used for?
Sotatercept-Csrk is an FDA-approved medication used to treat adults with pulmonary arterial hypertension (PAH).
How does Sotatercept-Csrk work?
Sotatercept-Csrk is an activin signaling inhibitor, which means it blocks the activity of activin in the body. By balancing signals for blood vessel growth, Sotatercept-Csrk prevents the blood vessels in the lungs from getting too thick.
How do I take Sotatercept-Csrk?
Your dose of Sotatercept-Csrk will be based on your weight in kilograms (kg). The first dose is typically 0.3 mg/kg injected under the skin. Three weeks after that, the typical dose is 0.7 mg/kg injected under the skin every 3 weeks as a maintenance dose.
Is it safe for me to take Sotatercept-Csrk?
Sotatercept-Csrk is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.
Sotatercept-Csrk Common Side Effects
Common side effects of Sotatercept-Csrk:
- Headache
- Nose bleeds
- Rash
- Spider veins
- Diarrhea
- Dizziness
- Skin redness
Sotatercept-Csrk Serious Side Effects
Serious side effects are rare with Sotatercept-Csrk. Contact your healthcare provider immediately if you experience any of the following:
- Signs or symptoms of a blood clot: redness or swelling of the legs, chest pain, difficulty breathing, weakness of the face, sudden confusion
- Severe bleeding: blood in the urine, stool that appears black and sticky, vomit that looks like coffee grounds, bruises that keep getting bigger
Effects of other drugs, drug classes and over-the-counter products on Sotatercept-Csrk
There are no major drug interactions listed for this medication. However, always let your physician and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking.
Who makes Sotatercept-Csrk?
Various FDA-approved generic manufacturers
Is Sotatercept-Csrk safe in pregnancy?
If you can get pregnant, make sure to use effective birth control while you’re taking Sotatercept-Csrk and for at least 4 months after your last dose. This medication can be harmful to an unborn baby.
What is the brand name for Sotatercept-Csrk?
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
OUR CUSTOMERS VIEW
What Customers Love About Our Service
We want everyone to be happy and healthy, that’s what keeps us going. Read what some of them have to say about us.
Medicines Experts
Meet Our Medical Team
We are a broad skilled and passionate group of clinicians with experience of operating in health systems in the United Kingdom & United States. Providing excellent care and advice is at the heart of everything we do. You can read more about our medical team by visiting the medical team page or learn more about how we curate content by visiting our editorial process

























